US Chloroform Prices Edge Down 0.85% in December 2025, Amid Cautious Year-End Demand

US Chloroform Prices Edge Down 0.85% in December 2025, Amid Cautious Year-End Demand

Marcel Proust 31-Dec-2025

The Final Week of December 2025 was a quiet week in the US Chloroform Market due to the balance between supply and limited downstream demand. The response from the market was one of caution and wait and see as producers-maintained contracts and did not focus on the spot market. While supply to the chlor alkali plants and the flow of raw materials continued without interruption, demand for Chloroform was limited, which had an overall negative effect on the market. Many Chloroform end user markets showed no growth in the last quarter of 2025, resulting in a very conservative approach regarding inventory replenishment and year-end adjustments. The supply chain for Chloroform remained intact through the holiday season, largely due to disciplined inventory processes and a lack of significant plant shutdowns. Continued international trade to countries such as Argentina, Japan and Mexico, remained at reasonable levels, with shipment levels remaining low due to weak demand in those areas. Overall, the Chloroform market closed out 2025 with a very balanced, yet uninspiring view of the ensuing year, predicting range-bound trading conditions in 2026.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
Tags:

Chloroform

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.